Simcere has strong technical strength and R&D capability in the field of biopharmaceuticals. The company has a professional R&D team with doctor's degree, master's degree and bachelor's degree, and has invested heavily in R&D and innovation, and developed a number of drugs with independent intellectual property rights. Among them, Abidol is one of the company's star products, which has been approved by the State Administration of Pharmaceutical Products to treat malignant tumors such as leukemia and lymphoma, with good therapeutic effect and safety.
In the future, simcere has a bright future. With the improvement of people's health awareness and medical level, the biopharmaceutical market will usher in greater development opportunities. Voice will continue to increase investment in research and development, introduce more innovative drugs with independent intellectual property rights, expand domestic and foreign markets, strengthen enterprise management and operation, and achieve sustainable development. It is believed that simcere will become one of the leading enterprises in biopharmaceutical industry in China in the future.
Simcere has strong technical strength and R&D capability in the field of biopharmaceuticals. The company has a professional R&D team with doctor's degree, master's degree and bachelor's degree, and has invested heavily in R&D and innovation, and developed a number of drugs with independent intellectual property rights. Among them, Abidol is one of the company's star products, which has been approved by the State Administration of Pharmaceutical Products to treat malignant tumors such as leukemia and lymphoma, with good therapeutic effect and safety.
In addition to technical strength, simcere also pays attention to quality management and market expansion. The company has passed ISO900 1 quality management system certification, GMP certification, drug registration certification and other certifications, ensuring the quality and safety of products. At the same time, the company actively expands the domestic and international markets, and its products have been exported to many countries and regions, becoming the leading pharmaceutical industry in China.